Skip to main content
Scilex Holding Co logo

Scilex Holding Co — Investor Relations & Filings

Ticker · SCLX ISIN · US80880W2052 LEI · 529900SPEA2C7YTTYP45 US Manufacturing
Open in API
Filings indexed 686 across all filing types
Latest filing 2023-01-03 Regulatory Filings
Country US United States of America
Listing US SCLX

About Scilex Holding Co

https://www.scilexholding.com/

Scilex Holding Co. is a company focused on the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company's portfolio targets indications with high unmet medical needs and features therapies with proprietary drug delivery systems. These systems include an advanced topical patch technology for optimized drug delivery through the skin, an anti-inflammatory oral solution designed for individualized dosing in high-risk patients, and a liquid ready-to-use analgesic for migraine relief. Scilex aims to provide effective alternatives to opioid medications to improve patient quality of life.

Recent filings

Filing Released Lang Actions
424B3
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed pursuant to the Securities Exchange Act of 1934. It provides preliminary unaudited financial results for the one and twelve months ended December 31, 2022, and other related information. The document includes a prospectus supplement and updates related to securities offerings but primarily focuses on financial condition and results of operations. It is not a full annual or quarterly report but a current report providing updates on financial results and other material events. Therefore, it fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous filings that do not fit other specific categories such as Annual Report or Interim Report. The document length and content confirm it is not merely an announcement but a substantive filing, yet it does not contain comprehensive financial statements typical of 10-K or IR filings.
2023-01-03 English
424B3
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed pursuant to the Securities Exchange Act of 1934. It provides preliminary unaudited financial results for the one and twelve months ended December 31, 2022, including sales estimates and cash position. The document explicitly states that these are preliminary results and have not been audited or reviewed by the independent auditor. It is not a full annual or quarterly report but a current report updating investors on recent financial condition and results. The presence of the Form 8-K header and the nature of the content indicate this is a Regulatory Filing (RNS) rather than a full Annual Report (10-K) or Interim Report (IR). The document is also over 7,800 characters, so it is not a brief announcement but a substantive regulatory filing. Therefore, the appropriate classification is Regulatory Filings (RNS).
2023-01-03 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text includes preliminary unaudited financial results for the year ended December 31, 2022, but explicitly states these are preliminary estimates and have not been audited or fully reviewed. The document does not contain full financial statements or comprehensive analysis typical of an Interim/Quarterly Report (IR) or Annual Report (10-K). It is a regulatory filing to disclose material financial information promptly. The document length is 4828 characters, which is relatively short and consistent with a Form 8-K filing. Therefore, the best classification is Regulatory Filings (RNS), as it is a general regulatory announcement that does not fit into more specific categories like Annual Report or Interim Report.
2023-01-03 English
Regulatory Filings 2022
Regulatory Filings
2022-12-28 English
424B3
Capital/Financing Update Classification · 95% confidence The document is a detailed prospectus filed pursuant to Rule 424(b)(3) related to the issuance and resale of shares and warrants of Scilex Holding Company. It includes extensive information about the business combination, share issuance, selling stockholders, risk factors, market information, management discussion and analysis, business overview, and legal proceedings. The document is not a simple announcement but a comprehensive offering document related to capital raising and securities registration. This fits the definition of a Capital/Financing Update (CAP) as it provides updates on company fundraising, financing activities, and capital structure changes. It is not an Annual Report, Earnings Release, or other report types. The length and content confirm it is a full prospectus related to financing activities.
2022-12-27 English
Capital/Financing Update 2022
Capital/Financing Update Classification · 95% confidence The document is a letter from Scilex Holding Company to the SEC requesting acceleration of effectiveness for a Registration Statement on Form S-1. It references the Securities Act of 1933 and the Securities Exchange Act of 1934, and specifically mentions the Registration Statement on Form S-1 filed on November 30, 2022. The content is a formal request related to a capital raising process, not a financial report or earnings release. The document length is short (2008 characters) and it is a correspondence related to a financing registration statement, which fits the category of Capital/Financing Update (CAP).
2022-12-23 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.